🔗 Share this article

An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to message these accounts privately for supplier links, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day British shipping. Vendors promote the substance there before directing customers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Professionals Voice Worries

Nevertheless, physicians and chemists have cautions that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals administering substances of uncertain source.

Several professionals stated the popularity for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the British medical regulations.

Some content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate medicines, advertising, and customer laws, potentially leading to fines, legal action or prison.

Platform Response and Content Removal

According to TikTok, the service has removed violative material and prohibited related keywords and query recommendations. The company said it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also discovered communities with up to nine thousand participants marketing the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, filled with photos of slimming results, glowing reviews and detailed guides for mixing or injecting at home.

After moments of joining one group, a seller posted contact information, where most transactions occur. The vendor provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about weight, health issues or previous experience.

Item Details and Costs

Inside these groups, posts show black plastic packages with Royal Mail labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with sterile water, or pre-filled injectors usually sold at £160 for 20 milligrams. When questioned how long a pen should last, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A representative for Telegram said it regularly moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting materials they can’t verify. Even if the research behind retatrutide is sound, these online products may not include what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in interest to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are using social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered individuals harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be contaminated or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company investigational product not yet approved … may expose users to potentially significant health risks”.